Clever Leaves granted Australian GMP certification for cannabis products

Clever Leaves Holdings has been granted Australian GMP certification for its facilities in Colombia by the Therapeutic Goods Administration, the regulatory body for health products in Australia. This certification authorizes Clever Leaves to manufacture cannabis products for patients in Australia, marking a significant achievement for the multinational operator. Similar to the stringent standards of the EU-GMP certification, the Australian GMP certification from the TGA ensures the delivery of the highest quality medicinal cannabis to patients. It safeguards against product contamination, variations in compound concentrations, mix-ups, incorrect labeling, and other potential issues. This certification is a prerequisite for the manufacturing and commercialization of cannabis products in the Australian market.